Table 5. Treatments for high vs. low RNLS levels in patients with locally advanced/borderline resectable pancreatic adenocarcinoma as compared to CA19-9.

RNLS
Factor	Low (n = 38)	High (n = 38)	aOR (95%CI)	p-value
Resection	13 (34.2%)	5 (13.2%)	0.29 (0.09–0.93)	0.036
Chemotherapy	36 (94.7%)	36 (97.3%)	2.00 (0.17–23.06)	0.578
Radiotherapy	18 (48.6%)	21 (58.3%)	1.48 (0.59–3.73)	0.408
CA19-9
Factor	Low (n = 14)	High (n = 8)	aOR (95%CI)	p-value
Resection	3 (42.9%)	3 (20.0%)	0.33 (0.05–2.37)	0.272
Chemotherapy	6 (85.7%)	15 (100.0%)	--	1.000
Radiotherapy	5 (71.4%)	7 (46.7%)	0.35 (0.05–2.41)	0.286